Distinguished in Ewing Sarcoma

Benedicte G. Brichard

Brussels, BRU, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Ewing Sarcoma
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Benedicte Brichard practices in Brussels, Belgium. Ms. Brichard is rated as a Distinguished expert by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Ewing Sarcoma, Infantile Myofibromatosis, Osteosarcoma, Bone Marrow Transplant, and Liver Transplant.

Her clinical research consists of co-authoring 67 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles in the study of Ewing Sarcoma.

Gender
Female

Locations

Brussels, BRU 1200, Belgium
Other Locations
Leuven, VLG, Belgium
Belgium
Avenue Hippocrate 10, Saint-lambert, WAL 1200, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Enrollment Status: Recruiting
Publish Date: May 01, 2025
Intervention Type: Genetic
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: Ramucirumab, Cyclophosphamide, Vinorelbine
Study Phase: Phase 1/Phase 2
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
Enrollment Status: Terminated
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drugs: Ramucirumab, Gemcitabine, Docetaxel
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trial

67 Total Publications

Perceptions and needs of NICU professionals regarding pediatric palliative care: a qualitative study compared with international literature.
Perceptions and needs of NICU professionals regarding pediatric palliative care: a qualitative study compared with international literature.
Journal: BMC palliative care
Published: August 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Brichard's expertise for a condition
ConditionClose
    View All 46 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile